Journal of Clinical & Medical Genomics

Integrating Radiomics and Genomics: Advancing Precision Medicine in Non-small Cell Lung Cancer

Abstract

Hannah Lara*

The integration of radiomics and genomics represents a pivotal advancement in precision medicine for non-small cell lung cancer (NSCLC). Radiomics utilizes advanced imaging techniques to extract quantitative data from medical images, offering insights into tumor heterogeneity and treatment response. Genomic analysis identifies molecular alterations driving cancer progression, facilitating targeted therapies. By combining these disciplines, clinicians can personalize treatment strategies, predict patient outcomes and optimize therapeutic efficacy. This synergistic approach holds promise for enhancing diagnostic accuracy, monitoring treatment response and ultimately improving survival outcomes in NSCLC patients.